Gundawar Ravi | Department of Pharmaceutical Quality Assurance - MCOPS, 必威体育betway888 Academy of Higher Education

Dr. Gundawar Ravi

Associate Professor

Date of Joining: 26.10.2021

Department of Pharmaceutical Quality Assurance

CURRENT ACADEMIC ROLE & RESPONSIBILITIES

Dr. Gundawar Ravi is an Associate Professor in the Department of Pharmaceutical Quality Assurance, 必威体育betway888 College of Pharmaceutical Sciences.

He is involved in the teaching of under postgraduate (PG) and undergraduate (UG) programs and research activities.

SUBJECTS CURRENTLY TEACHING

Subject	Semester / Year
Pharmaceutical Analysis (Theory)	B.Pharm Sem I
Pharmaceutical Analysis (Practical)	B.Pharm Sem I
Quality Control and Quality Assurance	M.Pharm Sem I
Pharmaceutical Quality Assurance Practical - I	M.Pharm Sem I
Documentation and Regulatory Writing	M.Pharm Sem I

ACADEMIC QUALIFICATIONS

Degree	Specialisation	Institute	Year of passing
Bachelore in Pharmacy	B. Pharm	JSS College of Pharmacy, Mysuru, Karnataka.	2011
Master in Pharmacy	Pharmaceutical Quality Assurance	JSS College of Pharmacy, Mysuru	2014
Ph.D.	Pharmaceutical Sciences	JSS College of Pharmacy, Mysuru	2018

Experience

Institution / Organisation	Designation	Role	Tenure
NSRT Pvt. Ltd. KASEZ, Gandhidham. (R&D Center-Rusan Pharma Ltd.)	必威体育betway888 Associate	必威体育betway888er	Nov - 2017 to Apr- 2019
MNR College of Pharmacy, Telangana	Associate Professor	Teaching and 必威体育betway888	May - 2019 to Oct - 2021

AREAS OF INTEREST, EXPERTISE AND RESEARCH

Area of Interest

Quality Assurance, Regulatory Affairs, Formulation 必威体育betway888 & Development

Professional Affiliations & Contributions

Evaluated Poster presentation Session & Participated as Co-Ordinator and Oral Presentation Evaluator for the Conference during PERCEPT-2020, A National Seminar on Pharmaceutical Education & 必威体育betway888 Challenges for Emerging Prospects & Trends at University College of Technology, Osmania University, Hyderabad held on 13^th & 14^th March 2020.?
?Worked as an Organizing Secretary for Youth Red Cross Society (YRC, 2019-20), India from MNR College of Pharmacy, Sangareddy.?
Evaluated Oral presentation Session during 4^th 必威体育betway888 conference on innovations in pharmaceutical sciences (ICIPS) at Guru Nanak Institutions, Hyderabad held on 9-10^th August, 2019.
?Participated as Accommodation Volunteer at the 67^th Indian pharmaceutical congress to be held at Mysuru from 19-21^st December 2015.

1. Aluri Nandini, Ravi G*. Process validation of sucralfate oral suspension. Int. J. Res. Pharm. Sci. 2021;12(3):2005-2013.

2. R. Nagaraju, U. Rajeswari, G. Ravi, P. Subhash Chandra Bose, Damineni Saritha. Development and in vitro Characterization of Intranasal Microemulsions of Sumatriptan Succinate for brain Targeting. 必威体育betway888 J. Pharm. Tech. 2021;14(4):2062-2068.

3. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, P. Srikanth Reddy, Sandeep Kanna. Development and Evaluation of oral controlled release tablets of oxybutynin using various polymers. 必威体育betway888 J. Pharm. Tech. 2020;13(8):3854-3860.

4. Asra Farooqi, Damineni Saritha, K. Anupama, P. Subhash Chandra Bose, G. Ravi. Formulation and in-vitro evaluation of Dasatinib bilayered tablets. Int. J. Creative Res. Thoughts. 2020;8(6):1208-1222.

5. R. Nagaraju, P. Subhash Chandra Bose, G. Ravi, Damineni Saritha, Valluru Ravi. A Review on Current status of Buccal drug delivery system. 必威体育betway888 J. Pharm. Tech. 2020;13(6):2954-2962.

6. S. Sivaprasad, P. Subhash Chandra Bose, Ch. Sadakvali, G. Ravi, V. Swathi. Formulation and characterization of saquinavir nanoparticles prepared by nanoprecipitation method. World J Pharm Res. 2020;9(5):2227-40.

7. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita, Sandeep Kanna. Design, Development and Evaluation of Isosorbide Mononitrate Orally Disintegrating Tablets. Int J Pharma Res Health Sci. 2020;8(2):3136-38.

8. Poreddy Srikanth Reddy, V. Alagarsamy, P. Subhash Chandra Bose, Damineni Sarita, Vuppula Sruthi, G. Ravi. Formulation and Evaluation of Zaltoprofen Immediate Release Tablets using Superdisintegrants. 必威体育betway888 J. Pharm. Tech. 2020;13(3):1152-56.

9. M. Nagaraju and G. Ravi. Formulation and in vitro evaluation of glipizide floating beads by using various polymers. World J Pharm Res. 2020;9(4):1479-91.

10. U. Kruthika, M. Sudhasree, J. Mounika, N. Tandava Krishna, M. Divya, A. Rajani, G. Ravi. Clinical pharmacist-led program on medication reconciliation and patient counseling in the department of Gastroenterology. Int J Pharm Pharm Sci. 2020;12(1):6-10.

11. G. Ravi, N. Vishal Guptal, Valluru Ravi, P. Subhash Chandra Bose, Damineni Sarita. A Quality by Design concept on polymer-based nanoparticles containing Anti-Alzheimer’s drug. J. Global Trends Pharm Sci. 2019;10(2):6181 – 95.

12. G. Ravi, Valluru Ravi, P. Subhash Chandra Bose, Damineni Saritha. Microsponges – A comprehensive review: Success and challenges. Indo American J Pharm Res. 2019;9(7):3056-67.

13. G. Ravi, N. Vishal Gupta. In vivo study of polymeric nanoparticles loaded transdermal film for the treatment of Alzheimer’s disease. Int. J. Pharm. Sci. Rev. Res. 2019;57(2):112-15.

14. R. Nagaraju, Damineni Saritha, P. Subhash Chandra Bose, G. Ravi, Valluru Ravi. A review on current status of self-emulsifying drug delivery systems. Int J Med Biomed Studies. 2019;3(7):232-48.

15. CH. Krishna Vamsi, A. Sushmitha, P. Supriya, A. Rajani, G. Ravi. Polypharmacy in hospitalized geriatric patients in a tertiary care hospital – A Prospective study. Int J Med Biomed Studies. 2019;3(10):63-67.

16. V. Spandana, B. Sindhuja, A. Rajani, G. Ravi. Gout-an Update. European J Biomedi Pharm Sci. 2019;6(12):219-22.

17. G. Ravi, P. Subhash Chandra Bose, Valluru Ravi, Damineni Sarita. Preparation, characterization and evaluation of Celecoxib loaded nanosponges for the treatment of Psoriatic arthritis. Int J Med Biomed Studies. 2019;3(12):181-85.

18. S Vennela, U Padma Latha, D Swathi, T Soundarya, CH Alekhya, A Rajani, G Ravi. A Prospective Study of Morbidity Pattern among Pregnant Women Attending at Tertiary Care Hospital. 必威体育betway888 Journal of Pharma 必威体育betway888 and Health Sciences. 2019;7(6):3095-100.

19. P Srikanth Reddy, P Subhash Chandra Bose, G Ravi, V Sruthi, Damineni Saritha. Phytochemical and Pharmacological Activities of Gynura lycopersicifolis and Gnaphalium polycaulon. 必威体育betway888 Journal of Pharma 必威体育betway888 and Health Sciences. 2019;7(6):3068-73.

20. Ravi G, Vishal Gupta N, Balamuralidhara V. Rivastigmine Tartrate Solid Lipid Nanoparticles Loaded Transdermal Film: An In vivo study. Res. J. Pharm. Tech. 2018;11(1):227-30.

21. G. Ravi, N. Vishal Gupta. Development of Solid lipid Nanoparticles of Rivastigmine Tartrate by using full factorial design for the treatment of Alzheimer’s disease. J. Pharm. Sci. Res. 2017;9(12):2447-52.

22. G. Ravi, N. Vishal Gupta, Gowrav MP. Development and evaluation of matrix diffusion controlled transdermal patches of Donepezil. J Pharm Sci. Res. 2017;11(6):686-92.

23. G. Ravi, N. Vishal Gupta, M. P. Gowrav. Microneedles - An archetype swing in transdermal drug delivery: A comprehensive review. Indo Am J Phar Res. 2017;7(1):7399-416.

24. G. Ravi, N. Vishal Gupta. Development and evaluation of transdermal film containing solid lipid nanoparticles of Rivastigmine tartrate. Int J App Pharm. 2017;9(6):85-90.

25. Ravi KSN, Gowrav MP, Gangadharappa HV, G Ravi. Management of Out of Specification (OOS) for Finished Product. Int J Pharm Clin Res. 2017;9(3):221-32.

26. Nataraj H.M, N. Vishal Gupta, G. Ravi. Validation of water purification system. Asian J. Pharm. Clin. Res. 2017;10(4):409-16.

27. Rahul Raj. S, N. Vishal Gupta, G. Ravi. Evaluation of process capability in manufacture of Anti-hypertensive tablets 10 mg. Asian J. Pharm. Clin. Res. 2017;10(4):477-82.

28. Nataraj H.M, N. Vishal Gupta, G. Ravi. Cleaning validation of cefalexin capsule. Int J Chem Tech Res. 2017;10(6):1083-95.

29. G. Ravi, N. Vishal Gupta, Gowrav MP. A review on recent trends and various preparation techniques of Polymeric nanoparticles. J. Chem. Pharm. Res. 2016;8(12):207-14.

30. G. Ravi, N. Vishal Gupta. The treatment of Alzheimer’s disease by using donepezil loaded transdermal patch. J. Chem. Pharm. Res. 2015;7(3):806-13.

31. G. Ravi, N. Vishal Gupta, Raghunandan HV., Shashikanth D. FDA Guidelines-For Out of Specifications (OOS) in Industries. Int. J. Pharm Tech Res. 2013;5(3):943-48.

Program

News

Event

Other